These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 519479)

  • 1. Effect of depot medroxyprogesterone acetate on vaginal bleeding in the puerperium.
    Murphy HM
    Br Med J; 1979 Dec; 2(6202):1400-1. PubMed ID: 519479
    [No Abstract]   [Full Text] [Related]  

  • 2. Depot medroxyprogesterone and vaginal bleeding in the puerperium.
    Thiery M; Staelens R; Sanctorum C; Cliquet RL
    Br Med J; 1980 Feb; 280(6212):481-2. PubMed ID: 7370545
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term use of depot medroxy progesterone acetate as a contraceptive.
    el-Mahgoub S; Karim M; Ammar R
    Acta Obstet Gynecol Scand; 1972; 51(3):251-5. PubMed ID: 5072160
    [No Abstract]   [Full Text] [Related]  

  • 4. Medroxyprogesterone acetate as an injectable contraceptive--its utility in Indian women.
    Jawalekar KS; Chitale MV
    J Obstet Gynaecol India; 1973 Feb; 23(1):55-7. PubMed ID: 4806729
    [No Abstract]   [Full Text] [Related]  

  • 5. Medroxyprogesterone acetate (MPA) for contraception.
    Sajadi HE; Borazjani G; Ardekany MS
    Int J Fertil; 1972; 17(4):217-20. PubMed ID: 4362389
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of medroxyprogesterone acetate as a contraceptive in conjunction with early postpartum rubella vaccination.
    Sharp DS; Macdonald H
    Br Med J; 1973 Nov; 4(5890):443-6. PubMed ID: 4758444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medroxyprogesterone acetate as a contraceptive.
    Hornemann B; Osler M
    Int J Fertil; 1972; 17(4):210-6. PubMed ID: 4362388
    [No Abstract]   [Full Text] [Related]  

  • 8. Injectable long-acting progestogen contraception: a neglected modality.
    Rosenfield AG
    Am J Obstet Gynecol; 1974 Oct; 120(4):537-48. PubMed ID: 4606673
    [No Abstract]   [Full Text] [Related]  

  • 9. [Depot medroxyprogesterone acetate as contraceptive agent].
    Duarte-Contreras A
    Rev Colomb Obstet Ginecol; 1973; 24(1):13-9. PubMed ID: 4804874
    [No Abstract]   [Full Text] [Related]  

  • 10. [Parenteral contraceptive drugs: depot progestins].
    Rabe T; Runnebaum B
    Wien Med Wochenschr; 1987 Nov; 137(20-21):474-9. PubMed ID: 2967589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [On the clinical use of depomedroxyprogesterone acetate as an antiovulatory and ovariostatic agent, especially in lactating puerperas].
    Mengaldo R
    Minerva Ginecol; 1974 Jun; 26(6):358-66. PubMed ID: 4858750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depo Provera: a review.
    Nash HA
    Contraception; 1975 Oct; 12(4):377-93. PubMed ID: 1104254
    [No Abstract]   [Full Text] [Related]  

  • 13. The use of sterile medroxyprogesterone acetate suspension as a contraceptive during a three-year period.
    Dodds GH
    Contraception; 1975 Jan; 11(1):15-23. PubMed ID: 1116356
    [No Abstract]   [Full Text] [Related]  

  • 14. Early experience with the contraceptive use of depot medroxyprogesterone acetate in an inner-city clinic population.
    Polaneczky M; Guarnaccia M; Alon J; Wiley J
    Fam Plann Perspect; 1996; 28(4):174-8. PubMed ID: 8853283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Depot medroxyprogesterone acetate: clinical and metabolic effects (lipids, glucose, hemostasis)].
    Hyjazi Y; Maes E; Hurlet A; Masure R; Vekemans M
    J Gynecol Obstet Biol Reprod (Paris); 1985; 14(1):93-103. PubMed ID: 3159786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depot medroxyprogesterone acetate for contraception: a continuing controversy.
    Int J Gynaecol Obstet; 1979; 16(5):433-41. PubMed ID: 35417
    [No Abstract]   [Full Text] [Related]  

  • 17. Depot medroxyprogesterone acetate (Depo-Provera) as a contraceptive preparation.
    Bloch B
    S Afr Med J; 1971 Jul; 45(28):777-80. PubMed ID: 5106836
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical aspects on the use of medroxyprogesterone injections as a contraceptive agent].
    de Sampalo Júnior LF; Neme B; Dantas ML; Santos AM; Scarpelli SA
    Matern Infanc (Sao Paulo); 1974; 33(2):235-40. PubMed ID: 4478846
    [No Abstract]   [Full Text] [Related]  

  • 19. The Food and Drug Administration and medroxyprogesterone acetate. What are the issues?
    Rosenfield A; Maine D; Rochat R; Shelton J; Hatcher RA
    JAMA; 1983 Jun; 249(21):2922-8. PubMed ID: 6221125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacological and clinical application of progestational hormone depot preparations].
    Andor J
    Gynakol Rundsch; 1978; 18(3-4):163-71. PubMed ID: 569621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.